{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:20:34Z","timestamp":1787019634476,"version":"build-2736575974"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T00:00:00Z","timestamp":1391644800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2334-14-66","type":"journal-article","created":{"date-parts":[[2014,2,6]],"date-time":"2014-02-06T19:01:12Z","timestamp":1391713272000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["In vitro susceptibility of Escherichia colistrains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004\u20132012)"],"prefix":"10.1186","volume":"14","author":[{"given":"Bei","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sainan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaohui","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,2,6]]},"reference":[{"issue":"12","key":"3014_CR1","first-page":"905","volume":"27","author":"B Zheng","year":"2011","unstructured":"Zheng B, Lv Y: Ministry of health national antimicrobial investigation Net 2010 report: bacterial distribution and resistance in urinary tract infections in male. Chin J Clin Pharmacol. 2011, 27 (12): 905-912.","journal-title":"Chin J Clin Pharmacol"},{"key":"3014_CR2","volume-title":"Performance standards for antimicrobial susceptibility testing; M100-S22","author":"Clinical and Laboratory Standards Institute","year":"2012","unstructured":"Clinical and Laboratory Standards Institute: Performance standards for antimicrobial susceptibility testing; M100-S22. 2012, Wayne, PA: Clinical and Laboratory Standards Institute"},{"issue":"Suppl 1","key":"3014_CR3","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.ijantimicag.2004.02.001","volume":"24","author":"T Muratani","year":"2004","unstructured":"Muratani T, Matsumoto T: Bacterial resistance to antimicrobials in urinary isolates. Int J Antimicrob Agents. 2004, 24 (Suppl 1): S28-S31.","journal-title":"Int J Antimicrob Agents"},{"issue":"1","key":"3014_CR4","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.diagmicrobio.2006.11.015","volume":"58","author":"KS Ko","year":"2007","unstructured":"Ko KS, Suh JY, Peck KR, Lee MY, Oh WS, Kwon KT, Jung DS, Lee NY, Song JH: In vitro activity of fosfomycin against ciprofloxacin-resistant or extended-spectrum beta-lactamase-producing Escherichia coli isolated from urine and blood. Diagn Microbiol Infect Dis. 2007, 58 (1): 111-115. 10.1016\/j.diagmicrobio.2006.11.015.","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"Suppl","key":"3014_CR5","doi-asserted-by":"publisher","first-page":"S37","DOI":"10.1016\/S0924-8579(12)70008-0","volume":"40","author":"PL Lu","year":"2012","unstructured":"Lu PL, Liu YC, Toh HS, Lee YL, Liu YM, Ho CM, Huang CC, Liu CE, Ko WC, Wang JH, et al: Epidemiology and antimicrobial susceptibility profiles of gram-negative bacteria causing urinary tract infections in the Asia-Pacific region: 2009\u20132010 results from the study for monitoring antimicrobial resistance trends (SMART). Int J Antimicrob Agents. 2012, 40 (Suppl): S37-S43.","journal-title":"Int J Antimicrob Agents"},{"issue":"5","key":"3014_CR6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.jmii.2010.08.012","volume":"44","author":"HY Liu","year":"2011","unstructured":"Liu HY, Lin HC, Lin YC, Yu SH, Wu WH, Lee YJ: Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan. J Microbiol Immunol Infect. 2011, 44 (5): 364-368. 10.1016\/j.jmii.2010.08.012.","journal-title":"J Microbiol Immunol Infect"},{"issue":"4","key":"3014_CR7","doi-asserted-by":"publisher","first-page":"637","DOI":"10.2165\/00003495-199753040-00007","volume":"53","author":"SS Patel","year":"1997","unstructured":"Patel SS, Balfour JA, Bryson HM: Fosfomycin tromethamine. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy as a single-dose oral treatment for acute uncomplicated lower urinary tract infections. Drugs. 1997, 53 (4): 637-656. 10.2165\/00003495-199753040-00007.","journal-title":"Drugs"},{"key":"3014_CR8","unstructured":"European Association of Urology, Guidelines on Urological Infections. [http:\/\/www.uroweb.org\/fileadmin\/guidelines\/Total_file_2013_large_guidelines_prints.pdf]"},{"issue":"12","key":"3014_CR9","doi-asserted-by":"publisher","first-page":"e004157","DOI":"10.1136\/bmjopen-2013-004157","volume":"3","author":"LD Qiao","year":"2013","unstructured":"Qiao LD, Zheng B, Chen S, Yang Y, Zhang K, Guo HF, Yang B, Niu YJ, Wang Y, Shi BK, et al: Evaluation of three-dose fosfomycin tromethamine in the treatment of patients with urinary tract infections: an uncontrolled, open-label, multicentre study. BMJ Open. 2013, 3 (12): e004157-10.1136\/bmjopen-2013-004157.","journal-title":"BMJ Open"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2334-14-66\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-66","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2334-14-66.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T22:57:40Z","timestamp":1630537060000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/1471-2334-14-66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,2,6]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["3014"],"URL":"https:\/\/doi.org\/10.1186\/1471-2334-14-66","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,2,6]]},"assertion":[{"value":"30 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"66"}}